Peptilogics
Nick Nystrom is the SVP & Head of Computation & Data at Peptilogics. Nick has also served as the Chief Technology Officer and the Chief Scientist at the Pittsburgh Supercomputing Center. Nick has a Ph.D. in Physics from Carnegie Mellon University and has conducted research in high-performance computing and Big Data, life sciences, computer science, chemistry, and other fields.
Nick Nystrom has a PhD in Computational Chemistry from the University of Pittsburgh, which they obtained in 1992. Nick also has a B.S. in Chemistry and Math from the University of Pittsburgh, which they obtained in 1985.
The team that Nick Nystrom works with is the Computation & Data team.
Peptilogics
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.